Molecular genetic analysis of the BRCA2 tumor suppressor gene region in cutaneous squamous cell carcinomas

Journal of Cutaneous Pathology

Volumn 35, Issue 1, 2008, Pages 1-9

  Gray, Sarah E ^a   Kay, Elaine ^a   Leader, Mary ^a   Mabruk, Mohamed ^a,b  

^a BEAUMONT HOSPITAL   (Ireland)

^b ADVANCED MEDICAL AND DENTAL INSTITUTE   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN;

ADULT; AGED; ALLELIC IMBALANCE; ARTICLE; CONTROLLED STUDY; EPIDERMIS; FEMALE; GENE LOCUS; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE MARKER; PROMOTER REGION; PROTEIN EXPRESSION; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; TELOMERE; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; BRCA2 PROTEIN; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; EPIDERMIS; FEMALE; GENES, BRCA2; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MOLECULAR BIOLOGY; NEOPLASM STAGING; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 37249074933     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2007.00760.x     Document Type: Article

References (67)

1. Boni R, Schuster C, Nehrhoff B, Burg G. Epidemiology of skin cancer. Neuro Endocrinol Lett 2002 23: 48.
2. World Health Organization. How common is skin cancer? Available at http://www.who.int/uv/faq/skincancer/en/index1.html (accessed 23 November 2006).
3. Boukamp P. Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis 2005 26: 1657 (epub 19 May 2005).
4. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B 2001 63: 8.
5. Ashton KJ, Weinstein SR, Maguire DJ, Griffiths LR. Chromosomal aberrations in squamous cell carcinoma and solar keratoses revealed by comparative genome hybridization. Arch Dermatol 2003 139: 876.
6. Quinn AG, Sikkink S, Rees JL. Basal cell carcinomas and squamous cell carcinomas of human skin show distinct patterns of chromosome loss. Cancer Res 1994 54: 4756.
7. Sikkink SK, Rehman I, Rees JL. Deletion mapping of chromosome 3p and 13q and preliminary analysis of the FHIT gene in human nonmelanoma skin cancer. J Invest Dermatol 1997 109: 801.
8. Sherr CJ. Cancer cell cycles. Science 1996 274: 1672.
9. O'Connor DP, Kay EW, Leader M, Murphy GM, Atkins GJ, Mabruk MJ. A high degree of chromosomal instability at 13q14 in cutaneous squamous cell carcinomas: indication for a role of a tumour suppressor gene other than Rb. Mol Pathol 2001 54: 165.
10. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995 378: 789.
11. Wang SC, Shao R, Pao AY, Zhang S, Hung MC, Su LK. Inhibition of cancer cell growth by BRCA2. Cancer Res 2002 62: 1311.
12. Sharan SK, Morimatsu M, Albrecht U, et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 1997 386: 804.
13. Wong AK, Pero R, Ormonde PA, Tavtigian SV, Bartel PL. RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J Biol Chem 1997 272: 31941.
14. Chen CF, Chen PL, Zhong Q, Sharp ZD, Lee WH. Expression of BRC repeats in breast cancer cells disrupts the BRCA2- Rad51 complex and leads to radiation hypersensitivity and loss of G(2)/M checkpoint control. J Biol Chem 1999 274: 32931.
15. Davies AA, Masson JY, McIlwraith MJ, et al. Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol Cell 2001 7: 273.
16. Venkitaraman AR. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 2002 108: 171.
17. Liu Y, West SC. Distinct functions of BRCA1 and BRCA2 in double-strand break repair. Breast Cancer Res 2002 4: 9 (epub 20 November 2001).
18. Milner J, Ponder B, Hughes-Davies L, Seltmann M, Kouzarides T. Transcriptional activation functions in BRCA2. Nature (Lond.) 1997 386: 772.
19. Fuks F, Milner J, Kouzarides T. BRCA2 associates with acetyltransferase activity when bound to P/CAF. Oncogene 1998 17: 2531.
20. Sharan SK, Pyle A, Coppola V, et al. BRCA2 deficiency in mice leads to meiotic impairment and infertility. Development 2004 131: 131.
21. Tutt A, Gabriel A, Bertwistle D, et al. Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification. Curr Biol 1999 9: 1107.
22. Daniels MJ, Wang Y, Lee M, Venkitaraman AR. Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2. Science (Wash. DC) 2004 306: 876.
23. Lomonosov M, Anand S, Sangrithi M, Davies R, Venkitaraman AR. Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility protein. Genes Dev 2003 17: 3017.
24. Stratton MR. Recent advances in understanding of genetic susceptibility to breast cancer. Hum Mol Genet 1996 5: 1515.
25. Easton DF, Bishop DT, Ford D, Crockford GP. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The breast cancer linkage consortium. Am J Hum Genet 1993 52: 678.
26. Casey G. The BRCA1 and BRCA2 breast cancer genes. Curr Opin Oncol 1997 9: 88.
27. Edwards SM, Kote-Jarai Z, Meitz J, et al. Cancer research UK/British prostate group UK familial prostate cancer study collaborators; British Association of urological surgeons section of oncology. Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet 2003 72: 1 (epub 9 December 2002)
28. Narod SA, Ford D, Devilee P, et al. An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast cancer linkage consortium. Am J Hum Genet 1995 56: 254.
29. The Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 1999 91: 1310.
30. Thorlacius S, Tryggvadottir L, Olafsdottir GH, et al. Linkage to BRCA2 region in hereditary male breast cancer. Lancet 1995 346: 544.
31. Naderi A, Couch FJ. BRCA2 and pancreatic cancer. Int J Gastrointest Cancer 2002 31: 99.
32. Hu N, Wang C, Han XY, et al. Evaluation of BRCA2 in the genetic susceptibility of familial esophageal cancer. Oncogene 2004 23: 852.
33. Collins N, McManus R, Wooster R, et al. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene 1995 10: 1673.
34. Gudmundsson J, Johannesdottir G, Bergthorsson JT, et al. Different tumour types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13. Cancer Res 1995 55: 4830.
35. Beckmann MW, Picard F, An HX, et al. Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer. Br J Cancer 1996 73: 1220.
36. Kwiatkowska E, Teresiak M, Breborowicz D, Mackiewicz A. Somatic mutations in the BRCA2 gene and high frequency of allelic loss of BRCA2 in sporadic male breast cancer. Int J Cancer 2002 98: 943.
37. Prechtel D, Werenskiold AK, Prechtel K, Keller G, Hofler H. Frequent loss of heterozygosity at chromosome 13q12-13 with BRCA2 markers in sporadic male breast cancer. Diagn Mol Pathol 1998 7: 57.
38. Gras E, Cortes J, Diez O, et al. Loss of heterozygosity on chromosome13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors. Cancer 2001 92: 787.
39. Takahashi H, Chiu HC, Bandera CA, et al. Mutations of the BRCA2 gene in ovarian carcinomas. Cancer Res 1996 56: 2738.
40. Lin YW, Sheu JC, Liu LY, et al. Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions. Eur J Cancer 1999 35: 1730.
41. Kirkpatrick H, Waber P, Hoa-Thai T, et al. Infrequency of BRCA2 alterations in head and neck squamous cell carcinoma. Oncogene 1997 14: 2189.
42. Sabbir MG, Roy A, Mandal S, Dam A, Roychoudhury S, Panda CK. Deletion mapping of chromosome 13q in head and neck squamous cell carcinoma in Indian patients: correlation with prognosis of the tumour. Int J Exp Pathol 2006 87: 151.
43. Sparano A, Quesnelle KM, Kumar MS, et al. Genome-wide profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization. Laryngoscope 2006 116: 735.
44. Huang XP, Wei F, Liu XY, et al. Allelic loss on 13q in esophageal squamous cell carcinomas from northern China. Cancer Lett 2002 185: 87.
45. Collins N, Wooster R, Stratton MR. Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers. Br J Cancer 1997 76: 1150.
46. Harada H, Tanaka H, Shimada Y, Shinoda M, Imamura M, Ishizaki K. Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma. Cancer Res 1999 59: 3724.
47. Hu N, Li G, Li WJ, et al. Infrequent mutation in the BRCA2 gene in esophageal squamous cell carcinoma. Clin Cancer Res 2002 8: 1121.
48. Valarmathi MT, Sawhney M, Deo SS, Shukla NK, Das SN. Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families. Hum Mutat 2004 23: 205.
49. Gray SE, Kay EW, Leader M, Mabruk MJ. Enhanced detection of microsatellite instability and mismatch repair gene expression in cutaneous squamous cell carcinomas. Mol Diagn Ther 2006 10: 327.
50. Zauber NP, Sabbath-Solitare M, Marotta SP, McMahon L, Bishop DT. Comparison of allelic ratios from paired blood and paraffin-embedded normal tissue for use in a polymerase chain reaction to assess loss of heterozygosity. Mol Diagn 1999 4: 29.
51. Nuovo GJ, Becker J. PCR in-situ hybridisation in viral detection. In Latchman DS, ed. PCR applications in pathology: principles and practice. Oxford University Press 1995 64. Oxford, England.
52. Cawkwell L, Bell SM, Lewis FA, Dixon MF, Taylor GR, Quirke P. Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer 1993 67: 1262.
53. Moll U, Lau R, Sypes MA, Gupta MM, Anderson CW. DNA-PK, the DNA activated protein kinase, is differentially expressed in normal and malignant human tissues. Oncogene 1999 18: 3114.
54. Rajan JV, Wang M, Marquis ST, Chodosh LA. Brca2 is co-ordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc Natl Acad Sci USA 1996 93: 13078.
55. Vaughn JP, Cirisano FD, Huper G, et al. Cell cycle control of BRCA2. Cancer Res 1996 56: 4590.
56. Bertwistle D, Swift S, Marston NJ, et al. Nuclear location and cell cycle regulation of the BRCA2 protein. Cancer Res 1997 57: 5485.
57. Wang SC, Lin SH, Su LK, Hung MC. Changes in BRCA2 expression during progression of the cell cycle. Biochem Biophys Res Commun 1997 234: 247.
58. Xia F, Taghian DG, DeFrank JS, et al. Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining. Proc Natl Acad Sci USA 2001 98: 8644 (epub 10 July 2001).
59. Vissac C, Peffault De Latour M, Communal Y, Bignon YJ, Bernard-Gallon DJ. Expression of BRCA1 and BRCA2 in different tumor cell lines with various growth status. Clin Chim Acta 2002 320: 101.
60. Andres JL, Fan S, Turkel GJ, et al. Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents. Oncogene 1998 16: 2229.
61. Yuan R, Fan S, Wang JA, et al. Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells. Prostate 1999 40: 37.
62. Wang S, Makino K, Su L, et al. Ultraviolet irradiation induces BRCA2 protein depletion through a p53-independent and protein synthesis-dependent pathway. Cancer Res 2001 61: 2838.
63. Gupta VK, Schmidt AP, Pashia ME, et al. Multiple regions of deletion on chromosome arm 13q in head-and-neck squamous-cell carcinoma. Int J Cancer 1999 84: 453.
64. Li G, Hu N, Goldstein AM, et al. Allelic loss on chromosome bands 13q11-q13 in esophageal squamous cell carcinoma. Genes Chromosomes Cancer 2001 31: 390.
65. Nawroz-Danish HM, Koch WM, Westra WH, et al. Lack of BRCA2 alterations in primary head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 1998 119: 21.
66. Shattuck TM, Kim TS, Costa J, et al. Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinoma. Clin Endocrinol (Oxf) 2003 59: 180.
67. ®): treatment (online). Available at http://www.cancer.gov/cancertopics/pdq/treatment/skin/ HealthProfessional/page3 (accessed 24 November 2006).